🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department

Recruitingn/aAges 65 Years - anyAllOhio State University
NCT06326424 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Delirium is highly prevalent and very bad for patients with dementia. Delirium is a dangerous medical condition that occurs in 6-38% of older Emergency Department patients and 70% of ICU patients. A person who develops delirium in the ED or hospital has a 12 times higher odds of being newly diagnosed with dementia in the next year compared to a similar patient who does not become delirious. Delirium is especially dangerous for persons living with Alzheimer Disease and Related Dementias (AD/ADRD). Persons living with ADRD have an almost 50% chance of developing delirium in the hospital. Clinicians are bad at recognizing delirium. A recent systematic review led by the Geriatric Emergency Care Applied Research network (NIH funded) found that current delirium screening tools are at most 64% sensitive, meaning that physicians can identify some phenotypes of delirium well, but cannot easily r

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * adults patients 65+ years old with a known diagnosis of dementia or medical team highly suspects or confirms dementia this visit. * Emergency Department visit and/or hospitalization anticipated to last \>4 more hours from the time of enrollment. Exclusion Criteria: * Intubation/mechanical ventilation * Patients undergoing a procedure requiring sedation * Patients who cannot consent due to cognitive impairment and do not have a legally authorized representative or caregiver present.
💊

What it tests

  • Empatica EmbracePlus
📍

Where

1 site
The Ohio State University Wexner Medical Center
Columbus, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy